Fluid in the lungs after heart surgery is treated with a combination of diuretics (water pills), breathing exercises, and sometimes a drainage procedure, depending on how much fluid has collected and what is causing it. Nearly all patients who undergo open-heart surgery develop at least a small amount of fluid around or inside the lungs, and in most cases it resolves on its own or with routine post-operative care. The picture gets more complicated when the fluid is large, recurrent, or driven by inflammation rather than simple surgical swelling, so understanding the cause matters as much as the treatment itself.
Why Fluid Builds Up After Heart Surgery
Heart surgery, especially any procedure that uses a heart-lung bypass machine, triggers a cascade of inflammation throughout the body. The bypass circuit exposes blood to artificial surfaces, activates the immune system’s complement pathway, and generates reactive oxygen molecules that damage the delicate lining of lung capillaries. That damage makes the capillary walls leakier than normal, allowing protein-rich fluid to seep into lung tissue and the space around the lungs.
On top of that, bypass circuits are primed with a large volume of crystalloid fluid that dilutes the blood’s natural proteins, particularly albumin. Lower albumin means less ability to hold fluid inside blood vessels, so even more fluid drifts outward into the lungs. Blood transfusions given during or after surgery can worsen the inflammatory response further.
Surgical technique also plays a role. In coronary artery bypass grafting (CABG), the internal mammary artery is often harvested from inside the chest wall. If the pleural membrane that lines the lung cavity is opened during this step, the rate of pleural effusion (fluid collecting in the space around the lung) rises. One comparative study found that roughly a quarter of patients whose pleura was opened still had an effusion on the fifth day after surgery, compared with fewer than one in fifteen whose pleura stayed intact.
Beyond these mechanical and inflammatory triggers, a condition called postpericardiotomy syndrome can develop days to weeks after surgery. This is an autoimmune reaction in which the body’s immune system attacks the membranes around the heart and lungs, producing pleuritic chest pain, fever, and new fluid collections.
Types of Fluid and When They Appear
Not all post-surgical lung fluid is the same, and the timing tells you a lot about the cause. Pleural effusions after CABG surgery fall into rough time windows: perioperative (first week), early (within a month), late (two to twelve months), and persistent (beyond six months).
Perioperative effusions, the most common type, are usually caused by diaphragm dysfunction or the mammary artery harvest and tend to resolve on their own. Early effusions showing up in the first few weeks are often linked to postpericardiotomy syndrome and may need anti-inflammatory treatment or even corticosteroids. Late effusions are a different beast: they tend to be yellowish exudates rich in lymphocytes rather than the bloody, eosinophil-heavy fluid seen in the early period.
There is also pulmonary edema, which is fluid inside the lung tissue itself rather than in the pleural space around the lung. This typically results from the inflammatory capillary leak described above, or from the heart struggling to pump effectively in the hours after surgery. Pulmonary edema is usually the more immediately dangerous scenario and is managed aggressively in the intensive care unit.
A rare but serious type of fluid is chylothorax, which occurs when the thoracic duct or its branches are injured during surgery, leaking milky lymphatic fluid into the chest. Chylothorax is uncommon after adult heart surgery but is a recognized complication in children undergoing congenital heart repair. It causes nutritional depletion, immune suppression, and dehydration, and often requires a staged treatment approach that may include dietary modification, drainage, and occasionally surgical repair.
How Doctors Detect It
The traditional first-line tool is a chest X-ray, and you will almost certainly have several of these in the days following surgery. But X-rays have real limitations when it comes to catching fluid early or distinguishing between different types of lung complications. A growing body of evidence shows that bedside lung ultrasound is significantly more sensitive. One prospective study after cardiothoracic surgery found that ultrasound picked up about 90% of pulmonary complications on the day of ICU admission, compared with 61% caught by X-ray, and it detected clinically significant problems earlier.
In children after congenital heart surgery, the gap is even wider. One study reported that lung ultrasound detected pulmonary edema with about 92% sensitivity versus 44% for X-ray. Ultrasound also caught pleural effusions at dramatically higher rates: 40% versus under 7% in one pediatric cohort.
If a significant effusion is found and the cause is unclear, your medical team may perform a thoracentesis, inserting a needle to withdraw a sample of the fluid for laboratory analysis. The fluid’s protein content, cell counts, and other markers help distinguish between a simple post-surgical collection, an inflammatory effusion from postpericardiotomy syndrome, an infection, or chylothorax. One thing to be aware of: diuretic therapy, which is nearly universal after heart surgery, can concentrate the proteins in pleural fluid and make a straightforward transudative effusion look like something more alarming on lab tests. This phenomenon, sometimes called a pseudoexudate, is common enough in cardiac surgery patients that clinicians should account for it before ordering further workup.
Diuretics and Other Medications
The workhorse treatment for post-surgical lung fluid is diuretics, and overwhelmingly that means furosemide (often known by the brand name Lasix). In one retrospective study of cardiac surgery patients, over 92% received post-operative diuretics, and the vast majority of those were started on furosemide alone. A smaller subset received a second diuretic, such as spironolactone or eplerenone, layered on top.
Furosemide works by forcing the kidneys to excrete more sodium and water, reducing the total fluid volume in your body and pulling fluid out of the lungs. The dosing is usually aggressive in the first couple of days and then tapered as your weight and fluid balance normalize. Your medical team will track your daily weight, urine output, and kidney function to guide the dose. Patients with low albumin levels or reduced kidney function sometimes respond less predictably to diuretics; in those cases, a medication called tolvaptan, which blocks a different water-regulation pathway, has shown some benefit.
When the fluid buildup stems from postpericardiotomy syndrome, diuretics alone are not enough because the root problem is inflammation, not simple fluid overload. Anti-inflammatory drugs like colchicine, nonsteroidal anti-inflammatory drugs, or corticosteroids are the standard approach for that condition.
In cases where the heart itself is struggling to pump effectively after surgery, medications that strengthen the heart’s contractions or improve blood vessel relaxation may be used in the ICU. These include dobutamine, milrinone, and levosimendan. Preliminary evidence suggests levosimendan may help wean patients off mechanical circulatory support and reduce the risk of pulmonary edema developing in that setting.
Breathing Exercises and Respiratory Support
Breathing exercises are one of the most accessible and effective tools you have for clearing fluid and preventing complications. The centerpiece for most patients is incentive spirometry, a simple handheld device that gives you a visual target to inhale against. It keeps your lungs expanded, prevents the small airways from collapsing (atelectasis), and helps mobilize fluid and secretions.
A randomized trial of coronary artery bypass patients found that those who used incentive spirometry consistently had blood oxygen levels on the third post-operative day that were back to their pre-surgery baseline, while patients who did not use it remained below baseline. The spirometry group also had lower blood pressure readings and respiratory rates closer to normal, suggesting better overall recovery.
Starting deep breathing exercises before surgery appears to matter as well. One trial that began incentive spirometry training in the pre-operative period found that the rate of pulmonary complications dropped from about 24% in the control group to roughly 3% in the deep-breathing group. The breathing group also spent less time on a ventilator and had shorter ICU and hospital stays.
Nurse-guided incentive spirometry, where a nurse actively coaches the patient through each session rather than simply handing over the device, has been shown to further reduce the number and duration of low-oxygen episodes after cardiac surgery, along with shorter hospital stays.
For patients who develop significant pulmonary edema and cannot maintain adequate oxygen on their own, non-invasive positive-pressure ventilation (BiPAP) is a step up from simple breathing exercises. A retrospective study found that BiPAP applied to patients with pulmonary edema after cardiac surgery produced a measurable improvement in blood oxygen levels within 30 minutes, particularly in those whose levels had dropped below a critical threshold.
When Fluid Needs to Be Drained
If a pleural effusion is large enough to cause significant breathlessness, or if it is not responding to diuretics, direct drainage becomes necessary. The standard procedure is thoracentesis: a needle or small catheter is inserted through the chest wall under ultrasound guidance to withdraw the fluid. In a study of post-cardiac-surgery patients with symptomatic pleural disease, thoracentesis was found to be relatively safe even in patients taking blood-thinning medications. Most effusions in that study remained self-limited after a single drainage, although patients with larger initial volumes had higher odds of needing a repeat procedure.
For recurrent effusions that keep coming back despite repeated drainage and medical therapy, an indwelling pleural catheter can be placed. This is a small, tunneled tube that stays in the chest wall and allows fluid to be drained at home on a regular schedule. While indwelling catheters are more commonly associated with cancer-related effusions, their use in non-malignant recurrent effusions is growing. A case report described successful use of an indwelling catheter in a patient with recurrent effusion from postpericardiotomy syndrome who could not tolerate anti-inflammatory medications.
Chylothorax follows its own treatment pathway. Conservative management starts with dietary changes, typically switching to a very low-fat diet or using medium-chain triglyceride formulas that bypass the lymphatic system. If chyle output remains high after a period of conservative treatment, interventional radiology can attempt to embolize the leaking thoracic duct. Surgical ligation of the duct is reserved for cases that fail both conservative and radiologic approaches. Because chylothorax is rare, no controlled trials have definitively established which approach is best, and treatment decisions are made case by case.
Fluid Balance and Kidney Support
Managing fluid after heart surgery is not only about the lungs. Your entire fluid balance matters, and the kidneys are central to the equation. Some patients develop acute kidney injury after cardiac surgery, and when the kidneys cannot clear fluid effectively, the lungs bear the consequences. In these cases, renal replacement therapy (a form of dialysis) may be used to directly remove excess fluid from the bloodstream through ultrafiltration.
An observational study of cardiac surgery patients who needed renal replacement therapy found that a positive fluid balance during the first day of therapy was an independent risk factor for death within 30 days. In other words, the faster excess fluid was removed, the better the outcomes. The survival group in that study had significantly lower total fluid balance and larger ultrafiltration volumes during the first three days of therapy.
Even without kidney failure, the surgical team closely monitors your daily fluid intake versus output. Intravenous fluids given during and after surgery contribute to the overall fluid load, so the post-operative strategy involves restricting IV fluids as soon as you are drinking on your own, continuing diuretics, and tracking weight daily to make sure net fluid is trending downward.
What You Can Do at Home
Once you are discharged, several practical steps help prevent fluid from re-accumulating. Sodium restriction is the single most impactful dietary change, because sodium causes your body to retain water. Most cardiac surgery recovery programs recommend limiting sodium intake and focusing on whole grains, lean proteins, fruits, and vegetables while avoiding processed and high-salt foods.
Continue any prescribed diuretics exactly as directed, even if you feel well. Weigh yourself every morning on the same scale, before eating, in similar clothing. A sudden gain of more than a couple of pounds overnight or several pounds over a few days is a red flag for fluid retention and should prompt a call to your surgical team or cardiologist. They may adjust your diuretic dose over the phone.
Keep up with your breathing exercises at home. Most programs recommend incentive spirometry several times a day for weeks after surgery, gradually transitioning to general physical activity as you heal. Walking is the single best form of exercise in the early recovery period: it keeps the lungs expanded, improves circulation, and helps the body clear retained fluid.
Watch for warning signs that fluid may be returning or that a new complication is developing. These include increasing shortness of breath, a dry cough that worsens when lying flat, chest pain that changes with breathing, fever, or a noticeable decrease in urine output. Any of these warrants medical attention rather than a wait-and-see approach.
Postpericardiotomy Syndrome and Late Effusions
Postpericardiotomy syndrome deserves special attention because it often catches patients off guard. You may feel like you are recovering well, only to develop new chest pain, fever, and breathlessness two to six weeks after surgery. The condition is an autoimmune reaction characterized by eosinophilia, pleuritic chest pain, and pleural effusions. It can be misinterpreted as pneumonia or a heart problem, delaying appropriate treatment.
The effusions from postpericardiotomy syndrome are inflammatory in nature and do not respond well to diuretics alone. Colchicine, which dampens the specific inflammatory pathway involved, has become a first-line treatment. Some surgeons now prescribe a short course of colchicine starting right after surgery to prevent the syndrome from developing in the first place, though practices vary. For patients who do not respond to colchicine or NSAIDs, corticosteroids are an option, though they come with their own risks during wound healing.
Late effusions, those appearing months after surgery, tend to be lymphocyte-predominant and exudative, with significantly lower enzyme levels compared to the bloody, eosinophil-rich fluid of the early post-operative period. These late collections can occasionally become persistent, lasting beyond six months, and may require repeated drainage or an indwelling catheter if medical management fails. The good news is that even persistent effusions after heart surgery are almost always benign. The key concern is distinguishing them from other causes of chronic effusion, which is where fluid analysis after thoracentesis becomes important.
How Surgical Technique Affects Your Risk
Not all heart surgeries carry the same risk of lung fluid complications. Any surgery using cardiopulmonary bypass carries the inflammatory burden described earlier, but the specific steps of the operation matter too. In CABG, whether the surgeon keeps the pleural membrane intact during mammary artery harvesting has a measurable impact on effusion rates and early lung function. Studies consistently show fewer complications when the pleura is preserved, including lower rates of atelectasis and pleural effusion.
Minimally invasive and off-pump techniques, which avoid the bypass machine entirely, generally produce less lung inflammation. Valve surgeries, which tend to require longer bypass times, may carry a somewhat higher risk of pulmonary edema. Congenital heart surgeries in children carry a unique risk of chylothorax due to the anatomic complexity of the procedures and the smaller, more vulnerable lymphatic structures in young patients.
Pre-existing conditions also influence risk. Patients who enter surgery with low albumin levels, kidney problems, or ongoing infections are more susceptible to fluid complications. Obesity, chronic lung disease, and older age compound the risk further. These factors do not change the fundamental treatment approach, but they do mean the medical team will watch more closely and may start diuretics or breathing exercises earlier and more aggressively.